Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Vitamin D Therapy Market

Vitamin D Therapy Market Share

Report ID: GMI9170
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Vitamin D Therapy Market Share

The vitamin D therapy industry is shaped by major pharmaceutical and supplement companies that dominate the market with a wide range of products and strong distribution networks. These companies continuously innovate to introduce new formulations and delivery methods that appeal to diverse consumer preferences. Strategic partnerships, brand trust, and adherence to regulatory standards play key roles in maintaining a competitive edge in this market.

Vitamin D Therapy Market Companies

Prominent players operating in the vitamin D therapy industry include:

Abbott Laboratories
Alkem Laboratories Ltd.
Atrium Innovations
Biotics Research Corporation
Cadila Healthcare Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Ortho Molecular Products
Pfizer, Inc.
Sanofi

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global vitamin D therapy market size was valued at USD 2.9 billion in 2023 and is anticipated to showcase growth at 11.4% CAGR from 2024 – 2032, due to increasing awareness of vitamin D deficiency and its health benefits across all age groups.

The OTC drugs segment accounted 58.7% of the market share in 2023, due to its accessibility and convenience for consumers.

North America vitamin D therapy market accounted for 41.3% revenue share in 2023 and is predicted to reach USD 3 billion by 2032, owing to high prevalence of vitamin D deficiency and aging population.

Abbott Laboratories, Alkem Laboratories Ltd., Atrium Innovations, Biotics Research Corporation, Cadila Healthcare Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Ortho Molecular Products, Pfizer, Inc., and Sanofi.